This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2001 Jul 19;345(3):211-5.

doi: 10.1056/NEJM200107193450311.

Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

B R Edlin¹, K H Seal, J Lorvick, A H Kral, D H Ciccarone, L D Moore, B Lo

Affiliations

PMID: 11463019
PMCID: PMC1510901
DOI: 10.1056/NEJM200107193450311

Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

B R Edlin et al. N Engl J Med. 2001.

. 2001 Jul 19;345(3):211-5.

doi: 10.1056/NEJM200107193450311.

Authors

B R Edlin¹, K H Seal, J Lorvick, A H Kral, D H Ciccarone, L D Moore, B Lo

Affiliation

¹ Urban Health Study, Institute for Health Policy Studies, University of California, San Francisco 94110, USA. bredlin@itsa.ucsf.edu

PMID: 11463019
PMCID: PMC1510901
DOI: 10.1056/NEJM200107193450311

No abstract available

PubMed Disclaimer

Comment in

Interferon alfa-induced adverse effects in patients with a psychiatric diagnosis.
Pariante CM, Landau S, Carpiniello B; Cagliari Group. Pariante CM, et al. N Engl J Med. 2002 Jul 11;347(2):148-9. doi: 10.1056/NEJM200207113470221. N Engl J Med. 2002. PMID: 12110753 No abstract available.

Similar articles

Treatment of chronic hepatitis C in active drug users.
Davis GL, Rodrigue JR. Davis GL, et al. N Engl J Med. 2001 Jul 19;345(3):215-7. doi: 10.1056/NEJM200107193450312. N Engl J Med. 2001. PMID: 11463020 No abstract available.
[Treatment of hepatitis C in intravenous drug users].
Filoche B. Filoche B. Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B252-6. Gastroenterol Clin Biol. 2002. PMID: 12180298 Review. French. No abstract available.
Elimination on the agenda for hepatitis C.
Burki T. Burki T. Lancet Infect Dis. 2014 Jun;14(6):452-3. doi: 10.1016/s1473-3099(14)70704-2. Lancet Infect Dis. 2014. PMID: 24971446 No abstract available.
[Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
Lucidarme D. Lucidarme D. Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B112-20. Gastroenterol Clin Biol. 2002. PMID: 12180278 Review. French. No abstract available.
Enhancing hepatitis C treatment uptake and outcomes for injection drug users.
Dore GJ. Dore GJ. Hepatology. 2007 Jan;45(1):3-5. doi: 10.1002/hep.21478. Hepatology. 2007. PMID: 17187427 No abstract available.

See all similar articles

Cited by

Hepatitis infection in the treatment of opioid dependence and abuse.
Kresina TF, Sylvestre D, Seeff L, Litwin AH, Hoffman K, Lubran R, Clark HW. Kresina TF, et al. Subst Abuse. 2008 Apr 28;1:15-61. doi: 10.4137/sart.s580. eCollection 2008. Subst Abuse. 2008. PMID: 25977607 Free PMC article. Review.
Injection drug users: the overlooked core of the hepatitis C epidemic.
Edlin BR, Carden MR. Edlin BR, et al. Clin Infect Dis. 2006 Mar 1;42(5):673-6. doi: 10.1086/499960. Epub 2006 Jan 20. Clin Infect Dis. 2006. PMID: 16447113 Free PMC article. No abstract available.
Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.
Sylvestre DL, Loftis JM, Hauser P, Genser S, Cesari H, Borek N, Kresina TF, Seeff L, Francis H. Sylvestre DL, et al. J Urban Health. 2004 Dec;81(4):719-34. doi: 10.1093/jurban/jth153. J Urban Health. 2004. PMID: 15466851 Free PMC article.
Hepatitis C virus infection in San Francisco's HIV-infected urban poor.
Hall CS, Charlebois ED, Hahn JA, Moss AR, Bangsberg DR. Hall CS, et al. J Gen Intern Med. 2004 Apr;19(4):357-65. doi: 10.1111/j.1525-1497.2004.30613.x. J Gen Intern Med. 2004. PMID: 15061745 Free PMC article.
Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV.
Weiss JJ, Gorman JM. Weiss JJ, et al. Curr HIV/AIDS Rep. 2006 Nov;3(4):176-81. doi: 10.1007/s11904-006-0013-2. Curr HIV/AIDS Rep. 2006. PMID: 17032577 Free PMC article. Review.

See all "Cited by" articles

References

1. Williams I. Epidemiology of hepatitis C in the United States. Am J Med. 1999;107(6B):2S–9S. - PubMed
1. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med. 2000;132:296–305. - PubMed
1. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med. 1998;339:1485–92. - PubMed
1. Normand J, Vlahov D, Moses LE, editors. Preventing HIV transmission: the role of sterile needles and bleach. National Academy Press; Washington, D.C.: 1995. - PubMed
1. Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) 1995;74:212–20. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information